Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medinotec (MDNC) EBIT (2022 - 2025)

Medinotec filings provide 4 years of EBIT readings, the most recent being $552712.0 for Q4 2025.

  • On a quarterly basis, EBIT rose 4.79% to $552712.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $3.3 million, a 124.42% increase, with the full-year FY2025 number at $3.2 million, up 431.4% from a year prior.
  • EBIT hit $552712.0 in Q4 2025 for Medinotec, up from $528565.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $2.0 million in Q1 2025 to a low of -$190616.0 in Q1 2022.
  • Median EBIT over the past 4 years was $251996.5 (2023), compared with a mean of $295100.5.
  • Biggest five-year swings in EBIT: surged 911.45% in 2023 and later increased 3.08% in 2025.
  • Medinotec's EBIT stood at $25499.0 in 2022, then surged by 911.45% to $257910.0 in 2023, then skyrocketed by 104.51% to $527451.0 in 2024, then rose by 4.79% to $552712.0 in 2025.
  • The last three reported values for EBIT were $552712.0 (Q4 2025), $528565.0 (Q3 2025), and $277457.0 (Q2 2025) per Business Quant data.